| Dr Mohamad Almasri, MD | |
|
2142 N Cove Blvd # 201, Toledo, OH 43606-3895 | |
| (419) 291-1111 | |
| (419) 479-3253 |
| Full Name | Dr Mohamad Almasri |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 2142 N Cove Blvd # 201, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063461754 | NPI | - | NPPES |
| 2200862 | Medicaid | OH | |
| 000000212607 | Other | OH | ANTHEM |
| 050084449 | Other | RAILROAD MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35074819 (Ohio) | Secondary |
| 207LC0200X | Anesthesiology - Critical Care Medicine | 35074819 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Promedica Toledo Hospital | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Promedica Central Physicians | 2365348190 | 818 |
News Archive
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) a global company pioneering the development of a cell implant therapy to treat diabetes and neurodegenerative diseases, has been granted a patent by the Australian Patent Office for IMMUPEL(tm), LCT's industry-leading technology for encapsulating living cells prior to transplantation.
Some doctors want to make Missouri's Medicaid program a little more like a health club. A proposal outlined by a pair of doctors Tuesday would create a pilot project in which primary care physicians would be paid a flat monthly amount for each Medicaid patient they accept (Lieb, 11/19).
Tissue engineers create artificial organs and tissues that can be used to develop and test new drugs, repair damaged tissue and even replace entire organs in the human body. However, current fabrication methods limit their ability to produce free-form shapes and achieve high cell viability.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of preclinical data in the Journal of Neuroimmunology finding that its lead development candidate VB-201 significantly delayed the onset and severity of experimental autoimmune encephalomyelitis (EAE) in mice, the commonly used Multiple sclerosis.
New research from psychologists at the Universities of Exeter and Cardiff shows that people can train their brains to become less impulsive, resulting in less risk-taking during gambling. The research could pave the way for new treatments for people with addictions to gambling, drugs or alcohol as well as impulse-control disorders, such as ADHD.
› Verified 1 days ago
| Entity Name | Promedica Central Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043270150 PECOS PAC ID: 2365348190 Enrollment ID: O20031211000226 |
News Archive
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) a global company pioneering the development of a cell implant therapy to treat diabetes and neurodegenerative diseases, has been granted a patent by the Australian Patent Office for IMMUPEL(tm), LCT's industry-leading technology for encapsulating living cells prior to transplantation.
Some doctors want to make Missouri's Medicaid program a little more like a health club. A proposal outlined by a pair of doctors Tuesday would create a pilot project in which primary care physicians would be paid a flat monthly amount for each Medicaid patient they accept (Lieb, 11/19).
Tissue engineers create artificial organs and tissues that can be used to develop and test new drugs, repair damaged tissue and even replace entire organs in the human body. However, current fabrication methods limit their ability to produce free-form shapes and achieve high cell viability.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of preclinical data in the Journal of Neuroimmunology finding that its lead development candidate VB-201 significantly delayed the onset and severity of experimental autoimmune encephalomyelitis (EAE) in mice, the commonly used Multiple sclerosis.
New research from psychologists at the Universities of Exeter and Cardiff shows that people can train their brains to become less impulsive, resulting in less risk-taking during gambling. The research could pave the way for new treatments for people with addictions to gambling, drugs or alcohol as well as impulse-control disorders, such as ADHD.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohamad Almasri, MD 333 N Summit St Fl 7, Toledo, OH 43604-1531 Ph: (419) 291-1111 | Dr Mohamad Almasri, MD 2142 N Cove Blvd # 201, Toledo, OH 43606-3895 Ph: (419) 291-1111 |
News Archive
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) a global company pioneering the development of a cell implant therapy to treat diabetes and neurodegenerative diseases, has been granted a patent by the Australian Patent Office for IMMUPEL(tm), LCT's industry-leading technology for encapsulating living cells prior to transplantation.
Some doctors want to make Missouri's Medicaid program a little more like a health club. A proposal outlined by a pair of doctors Tuesday would create a pilot project in which primary care physicians would be paid a flat monthly amount for each Medicaid patient they accept (Lieb, 11/19).
Tissue engineers create artificial organs and tissues that can be used to develop and test new drugs, repair damaged tissue and even replace entire organs in the human body. However, current fabrication methods limit their ability to produce free-form shapes and achieve high cell viability.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of preclinical data in the Journal of Neuroimmunology finding that its lead development candidate VB-201 significantly delayed the onset and severity of experimental autoimmune encephalomyelitis (EAE) in mice, the commonly used Multiple sclerosis.
New research from psychologists at the Universities of Exeter and Cardiff shows that people can train their brains to become less impulsive, resulting in less risk-taking during gambling. The research could pave the way for new treatments for people with addictions to gambling, drugs or alcohol as well as impulse-control disorders, such as ADHD.
› Verified 1 days ago
Rashid Khalil, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4126 N Holland Sylvania Rd, Suite 220, Toledo, OH 43623 Phone: 419-517-7624 Fax: 419-517-7656 | |
Dr. Wei Sun Jueng, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2142 N Cove Blvd, Toledo, OH 43606 Phone: 419-471-4491 Fax: 419-479-6905 | |
Kevin Raduege, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2213 Cherry St, Toledo, OH 43608 Phone: 419-251-3232 | |
Dr. Jay Hammerling, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2142 N Cove Blvd, Toledo, OH 43606 Phone: 419-291-4491 Fax: 419-479-6905 | |
Jennifer Renee Spitler, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2213 Cherry St, Toledo, OH 43608 Phone: 419-251-6530 | |
Dr. Thomas A Rooney, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Anesthesia, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-383-3550 |